L.B. Bohle rejuvenates management team
Inauguration of the Technology Center: Continuous production on its way to practical application
Leading position defended
"We have defended our leading position in the 2014 business year and made further investments in innovations," said Lorenz Bohle. The gradual development of lean production in Plant 3 has made further progress. Therefore we have achieved further optimization of the production processes within a very short period of time. Faster delivery is leveraged as a competitive edge in the sales offensive. "We are striving to achieve double-digit growth in the current business year and have already generated a large proportion of the envisaged order intake," commented Lorenz Bohle with optimism. The contacts established at ACHEMA are to provide further impetus.
Platform for knowledge transfer
At the Bohle Technology Center, customers, scientists and cooperation partners can draw on an ideal platform for the advancement of continuous production processes. In the high-tech building with impressive architecture, solutions for direct compression, wet granulation and dry compacting are presented. "Permanent measuring, monitoring and control of the production throughout the entire process is decisive for the customers," explained Lorenz Bohle. According to Lorenz Bohle, there still is vast potential in the development of innovative continuous production processes.
Personnel changes
The owner of the company has also set the course for future growth through personnel changes. "Our long-standing Sales Manager Tim Remmert joined the management board in early 2015 and is going to assume additional responsibility for strategic tasks," explained Lorenz Bohle. Moreover, the Manager Scientific Operations, Dr. Hubertus Rehbaum, was promoted to the management team as Assistant Managing Director. Thorsten Wesselmann has taken on the position of Head of Technical Operation.
Focus on growth
The financial situation of L.B. Bohle Maschinen + Verfahren GmbH remained sound in 2014. "We have maintained our equity ratio of about 50 percent," Lorenz Bohle reported. Investments are financed through ongoing business activities. "With a sales offensive, the rejuvenated management team and potential cooperation partners, we are optimally prepared for 2015," said Lorenz Bohle.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.